These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts.
    Author: Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    Journal: Hum Immunol; 2012 Jan; 73(1):26-30. PubMed ID: 22019504.
    Abstract:
    CC chemokine ligand 20 (CCL20) plays a pivotal role in the recruitment of T-helper (Th)-17 cells and thus in the development of periodontal disease, but the effect of simultaneous interleukin (IL)-17A and IL-1β stimulation on CCL20 production in human gingival fibroblasts (HGFs) are not known. In this study, we investigated the mechanisms of IL-1β- and IL-17A-induced CCL20 production in HGFs. IL-17A synergistically enhanced CCL20 production from IL-1β-stimulated HGFs in a concentration-dependent manner. Extracellular signal-regulated kinase (ERK) and inhibitor of nuclear factor (NF)-κB-α phosphorylation were increased in IL-1β- and IL-17A-stimulated HGFs. Inhibitors of or ERK and NF-κB decreased IL-1β- and IL-17A-induced CCL20 production. IL-1β stimulation elevated IL-17 receptor C expression on HGFs. These data suggest that IL-1β is actively related to Th17 cell migration into peripheral tissues to induce production of the Th17 chemokine, CCL20. Therefore, IL-1β might be a therapeutic target for Th17-related diseases, such as periodontal disease and arthritis.
    [Abstract] [Full Text] [Related] [New Search]